Abstract:BackgroundCurcumin, extracted from the spice turmeric is commonly used in traditional Chinese and Indian medicine, has attracted increased interest for treating chronic inflammatory diseases owing to its antioxidant and anti-inflammatory properties. It has been reported that curcumin scavenges free radicals and their reactive metabolites due to its antioxidant activity, and blocks the free radical mediated inflammatory responses resulting in its anti-inflammatory activity. However, it has limited medical use due to its low oral bioavailability largely attributed to its low aqueous solubility. Its low intestinal adsorption is exacerbated by its rapid metabolism and excretion. Several approaches including the use of emulsions, micro-/nano-crystallised formulations, liposomes, cyclodextrin-complexes, conjugation with water soluble polymers, self-assembled particles and nanogels have been proposed to improve the oral bioavailability of curcumin. However, these approaches are difficult to manufacture in a large scale and require expensive machinery. The approach in the current work is to develop a cost-effective and scalable solid oral formulation of curcumin with enhanced bioavailability using water soluble polymers. MethodsCurcumin formulations were prepared through melt-granulation process. Curcumin was dissolved in polyethylene glycol (PEG) and PEG-block copolymer. A series of curcumin to PEG and PEG-block copolymer compositions were tested to maximise curcumin aqueous solubility. Loading of different curcuminoids in the formulation and their aqueous solubility was determined using HPLC along with their dissolution profile. The observations from the new curcumin formulations were compared to a commercially available curcumin product.ResultsDissolving curcumin in PEG can ensure its dispersion at molecular level in aqueous environments, the addition of PEG-bloc-copolymer can further stabilise this dispersion thus, resulted in the increased curcumin aqueous solubility. The results demonstrated that the new formulation can deliver 60mg of curcumin per capsule and showed faster and higher rate of release of curcumin in the soluble form both in simulated gastric conditions and intestinal conditions compared to the commercial comparator.ConclusionThe formulations showed enhanced dissolution and were relatively simple to produce. The PEG-block copolymer increased curcumin aqueous solubility by forming a water soluble complex with the drug. Future work involving in vivo supplementation studies are required to confirm these in vitro observations.

Bioanalysis of ursodeoxycholic acid and its metabolites and improved oral bioavailability using mixed micelles with poloxamer 407 and polysorbate 80

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nanosuspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.

Pharmacokinetics and Enhanced Oral Bioavailability in Beagle Dogs of Cyclosporine A Encapsulated in Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles

Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles As Oral Drug Delivery Systems: I. in Vitro Evaluation and Enhanced Oral Bioavailability of the Poorly Water-Soluble Drug Simvastatin

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review

Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride

Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles

In vitro and in vivo performance of amorphous solid dispersions of ursolic acid as a function of polymer type and excipient addition

A Validated Surrogate Analyte UPLC-MS/MS Assay for Quantitation of TUDCA, TCDCA, UDCA, and CDCA in Rat Plasma: Application in a Pharmacokinetic Study of Cultured Bear Bile Powder.

Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid

Fabrication of deoxycholic acid-modified polymeric micelles and their transmembrane transport

Preparation and Body Distribution of Freeze-Dried Powder of Ursolic Acid Phospholipid Nanoparticles

An ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of obeticholic acid in rat plasma and its application in preclinical pharmacokinetic studies

Stearic Acid-G-chitosan Polymeric Micelle for Oral Drug Delivery: in Vitro Transport and in Vivo Absorption.

Development of curcumin formulations with enhanced bioavailability for oral drug delivery

Preparation and Evaluation of Wet-Milled Usnic Acid Nanocrystal Suspension for Better Bioaffinity.

Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.

Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies

Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study

Revealing Changes in Celecoxib Nanostructured Lipid Carrier's Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS